Women surgeons and Mohs micrographic surgery in the U.S.

October 21, 2020

Michelle Nguyen, M.D., MPH, sits down with Dermatology Times to discuss her recent presentation at the 2020 American Society for Dermatologic Surgery (ASDS) virtual meeting regarding the representation of women dermatologic surgeons in the U.S.

Trial compares NMSC destructive techniques
Dupilumab provides option for severe AD in younger children
The Mainstream Patient: October 20
Older adults underrepresented in atopic dermatitis research

Negotiating better managed care contracts

October 20, 2020

Jerri Ivey, director of revenue cycle management at VitalSkin Dermatology, shares steps you can take and ways you can educate yourself in order to negotiate better managed care contracts. 

Weekly Roundup: October 12-16

October 16, 2020

ICYMI, some of the content featured this week includes new 730 nm picosecond laser for benign pigmented lesions, managing patient volumes during the COVID-19 pandemic, tips on how to build your brand as a physician, plus more.

Phenotype-based approach advances management

October 16, 2020

The 21-member global ROSacea Consensus panel developed updated recommendations for rosacea, diagnosis, classification and management to support and promote transition to a phenotype approach in rosacea.

Misinformation delays rosacea diagnosis in skin of color patients

October 16, 2020

The idea that rosacea is uncommon in darker skinned individuals may be due to under-recognition. Careful clinical examination, a thorough history and biopsy in some cases are needed for accurate diagnosis and differentiating rosacea from diseases that may be more common.

Managing pandemic patient volumes

October 15, 2020

Since the start of the pandemic, dermatologists have seen an average 50% drop in patient volume. While teledermatology has offered a channel for non-urgent patients and patient visits are rebounding, overall patient volumes are still significantly lower than 2019.

730 nm picosecond laser safe, effective for benign pigmented lesions

October 13, 2020

Lasers typically used for tattoo removal are on the rise as a possible treatment for melasma, with the novel 730 nm picosecond laser (PicoWay, Candela) being the most recently studied device which showed to be safe and effective for treating benign pigmented lesions.

The Mainstream Patient: October 12

October 12, 2020

This week’s edition of The Mainstream Patient features stories about a new toxic-free cosmetics bill in California, the benefits of benzoyl peroxide for acne, the legitimacy of collagen supplements, potential sunscreen changes by the FDA, plus more.

3D imaging technique measures severity of atrophic acne scars

October 11, 2020

There is a dire need to improve the clinical tools dermatologists use to assess the severity of acne scars. This 3D imaging technique may help, according to a recent study presented at the 2020 virtual American Society for Dermatologic Surgery (ASDS) meeting.

Distinguishing scar from neoplasm using HF ultrasound

October 11, 2020

Dr. Jack Levy, chief resident in the Department of Dermatology at Emory University, discusses his recent presentation at the 2020 ASDS meeting about using high frequency ultrasound to distinguish scar tissue from neoplasm.

Diagnostic concordance lacking in poorly differentiated SCC

October 10, 2020

A recent study underscores the need for a consistent scale to grade risk levels of cutaneous squamous cell carcinoma (SCC), particularly poorly differentiated tumors, according to study authors who presented at the 2020 virtual American Society for Dermatologic Surgery (ASDS) meeting.

Melanoma in situ: Imaging technique improves margin mapping

October 10, 2020

Performing reflectance confocal microscopy (RCM) with a mosaic technique before surgery can improve margin mapping in melanoma in situ (MIS), according to a recent study presented at 2020 ASDS Virtual Annual Meeting.

Weekly Roundup: October 5-9

October 09, 2020

ICYMI, some of the content featured this week includes articles about abobotulinumtoxinA injections for oily forehead, promising therapies for blastic plasmacytoid dendritic cell neoplasm (BPDCN), the benefits of CBD for the skin, plus more.

Nuances influence the neuromodulator decision

October 09, 2020

Experts share best practices for optimizing treatments using neuromodulators, assessing the next breakthrough products and avoiding complications at the American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting.